The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds
Open accessAbstract
From wedding rings on fingers to stained glass windows, by way of Olympic medals, gold has been highly prized for millennia. Nowadays, organometallic gold compounds occupy an important place in the field of medicinal inorganic chemistry due to their unique chemical properties with respect to gold coordination compounds. In fact, several studies have proved that they can be used to develop highly efficient metal-based drugs with possible applications in the treatment of cancer. This Perspective summarizes the results obtained for different families of bioactive organometallic gold compounds including cyclometallated gold(iii) complexes with C,N-donor ligands, gold(I) and gold(I/III) N-heterocyclic (NHC) carbene complexes, as well as gold(I) alkynyl complexes, with promising anticancer effects. Most importantly, we will focus on recent developments in the field and discuss the potential of this class of organometallic compounds in relation to their versatile chemistry and innovative mechanisms of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, mechanism and regulation of peroxiredoxins
Wood, Z. A., Schröder, E., Robin Harris, J., & Poole, L. B. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)00003-8 · Cited by 2,544
Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?
Balasubramanian, S., Hurley, L. H., & Neidle, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3428 · Cited by 1,692
Gölitz, P. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209858 · Cited by 922
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs
Liu, W., & Gust, R. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35314h · Cited by 762
Hickey, J. L., Ruhayel, R. A., Barnard, P. J., Baker, M. V., Berners-Price, S. J., & Filipovska, A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja804027j · Cited by 599
Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs
Bindoli, A., Rigobello, M. P., Scutari, G., Gabbiani, C., Casini, A., & Messori, L. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.026 · Cited by 595
Self-citationThe application of DNA and RNA G-quadruplexes to therapeutic medicines
Collie, G. W., & Parkinson, G. N. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15067g · Cited by 589
G-quadruplex nucleic acids as therapeutic targets
Balasubramanian, S., & Neidle, S. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.04.637 · Cited by 586
N-Heterocyclic carbene metal complexes in medicinal chemistry
Oehninger, L., Rubbiani, R., & Ott, I. (2013) · Dalton Trans. · doi:10.1039/c2dt32617e · Cited by 560
Gold compounds as therapeutic agents for human diseases
Berners-Price, S. J., & Filipovska, A. (2011) · Metallomics · doi:10.1039/c1mt00062d · Cited by 495
Role of membrane potential in the regulation of cell proliferation and differentiation
Sundelacruz, S., Levin, M., & Kaplan, D. L. (2009) · Stem Cell Reviews and Reports · doi:10.1007/s12015-009-9080-2 · Cited by 489
Deubiquitinases in cancer: new functions and therapeutic options
Fraile, J. M., Quesada, V, Rodríguez, D., Freije, J. M. P., & López-Otín, C. (2012) · Oncogene · doi:10.1038/onc.2011.443 · Cited by 453
Targeting the mitochondrial cell death pathway with gold compounds
Barnard, P. J., & Berners-Price, S. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2007.04.006 · Cited by 417
de Graaf, I. A. M., Olinga, P., de Jager, M. H., Merema, M. T., de Kanter, R., van de Kerkhof, E. G., & Groothuis, G. M. M. (2010) · Nature Protocols · doi:10.1038/nprot.2010.111 · Cited by 411
Organometallic ruthenium-based antitumor compounds with novel modes of action
Ang, W. H., Casini, A., Sava, G., & Dyson, P. J. (2011) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2010.11.009 · Cited by 366
Self-citationA categorization of metal anticancer compounds based on their mode of action
Gianferrara, T., Bratsos, I., & Alessio, E. (2009) · Dalton Transactions · doi:10.1039/b905798f · Cited by 336
Chemistry in human telomere biology: structure, function and targeting of telomere DNA/RNA
Xu, Y. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00134a · Cited by 323
Marcon, G., Carotti, S., Coronnello, M., Messori, L., Mini, E., Orioli, P., Mazzei, T., Cinellu, M. A., & Minghetti, G. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010997w · Cited by 266
Schuh, E., Pflüger, C., Citta, A., Folda, A., Rigobello, M. P., Bindoli, A., Casini, A., & Mohr, F. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300428v · Cited by 246
Self-citationGold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions
Pia Rigobello, M., Messori, L., Marcon, G., Agostina Cinellu, M., Bragadin, M., Folda, A., Scutari, G., & Bindoli, A. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.04.020 · Cited by 213
Molecular Mechanisms and Proposed Targets for Selected Anticancer Gold Compounds
Casini, A., & Messori, L. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611798040732 · Cited by 196
Self-citationCasini, A., Cinellu, M. A., Minghetti, G., Gabbiani, C., Coronnello, M., Mini, E., & Messori, L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060436a · Cited by 194
Self-citationOn the Biological Properties of Alkynyl Phosphine Gold(I) Complexes
Meyer, A., Bagowski, C. P., Kokoschka, M., Stefanopoulou, M., Alborzinia, H., Can, S., Vlecken, D. H., Sheldrick, W. S., Wölfl, S., & Ott, I. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201202939 · Cited by 187
Vessières, A., Top, S., Beck, W., Hillard, E., & Jaouen, G. (2006) · Dalton Trans. · doi:10.1039/b509984f · Cited by 180
Cyclometalated gold(iii) complexes with N-heterocyclic carbene ligands as topoisomerase I poisons
Yan, J. J., Chow, A. L.-F., Leung, C.-H., Sun, R. W.-Y., Ma, D.-L., & Che, C.-M. (2010) · Chemical Communications · doi:10.1039/c001216e · Cited by 179
Anti-cancer potential of gold complexes
Tiekink, E. R. T. (2008) · Inflammopharmacology · doi:10.1007/s10787-007-0018-5 · Cited by 166
Hartinger, C. G., Groessl, M., Meier, S. M., Casini, A., & Dyson, P. J. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35532b · Cited by 157
Self-citationCisplatin and Related Anticancer Drugs: Recent Advances and Insights
Barnes, K. R., & Lippard, S. J. (2004) · CRC Press eBooks · doi:10.1201/b12414-5 · Cited by 147
Cysteine proteases as targets for metal-based drugs
Fricker, S. P. (2010) · Metallomics · doi:10.1039/b924677k · Cited by 144
Citta, A., Schuh, E., Mohr, F., Folda, A., Massimino, M. L., Bindoli, A., Casini, A., & Rigobello, M. P. (2013) · Metallomics · doi:10.1039/c3mt20260g · Cited by 139
Self-citationCasini, A., Kelter, G., Gabbiani, C., Cinellu, M. A., Minghetti, G., Fregona, D., Fiebig, H., & Luigi Messori, A. (2009) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0558-9 · Cited by 138
Self-citationIsolation of Neutral Mono‐ and Dinuclear Gold Complexes of Cyclic (Alkyl)(amino)carbenes
Weinberger, D. S., Melaïmi, M., Moore, C. E., Rheingold, A. L., Frenking, G., Jerabek, P., & Bertrand, G. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201304820 · Cited by 134
Gold(I)-Mediated Inhibition of Protein Tyrosine Phosphatases: A Detailed in Vitro and Cellular Study
Krishnamurthy, D., Karver, M. R., Fiorillo, E., Orrù, V., Stanford, S. M., Bottini, N., & Barrios, A. M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800101w · Cited by 127
Rackham, O., Shearwood, A.-M. J., Thyer, R. T., McNamara, E. L., Davies, S. M. K., Callus, B. A., Miranda‐Vizuete, A., Berners‐Price, S. J., Cheng, Q., Arnér, E. S. J., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.015 · Cited by 126
Rubbiani, R., Schuh, E., Meyer, A., Lemke, J., Wimberg, J., Metzler‐Nolte, N., Meyer, F., Mohr, F., & Ott, I. (2013) · MedChemComm · doi:10.1039/c3md00076a · Cited by 118
Sun, R. W., Lok, C., Fong, T. T., Li, C. K.-L., Yang, Z. F., Zou, T., Siu, F., & Che, C. (2013) · Chemical Science · doi:10.1039/c3sc21972k · Cited by 113
Excursions in polynuclear platinum DNA binding
Mangrum, J. B., & Farrell, N. P. (2010) · Chemical Communications · doi:10.1039/c0cc01254h · Cited by 110
Gabbiani, C., Mastrobuoni, G., Sorrentino, F., Dani, B., Rigobello, M. P., Bindoli, A., Cinellu, M. A., Pieraccini, G., Luigi Messori, A., & Casini, A. (2010) · MedChemComm · doi:10.1039/c0md00181c · Cited by 110
Self-citationOrganogold(III) Supramolecular Polymers for Anticancer Treatment
Zhang, J., Lu, W., Sun, R. W., & Che, C. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201108466 · Cited by 97
Zhang, J., Sun, R. W., & Che, C. (2012) · Chemical Communications · doi:10.1039/c2cc00029f · Cited by 87
Iminophosphorane–organogold(III) complexes induce cell death through mitochondrial ROS production
Vela, L., Contel, M., Palomera, L., Azaceta, G., & Marzo, I. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.06.004 · Cited by 62
Thioredoxin reductase and cancer cell growth inhibition by organogold(III) compounds
Engman, L., McNaughton, M., Gajewska, M., Kumar, S., Birmingham, A., & Powis, G. (2006) · Anti-Cancer Drugs · doi:10.1097/00001813-200606000-00007 · Cited by 54
Deubiquitinases as potential anti-cancer targets for gold(III) complexes.
Zhang, J.-J., Ng, K., Lok, C.-N., Sun, R. W., & Che, C. (2013) · Chemical Communications · doi:10.1039/c3cc41766b · Cited by 43
Cited by
Encyclopedia of Inorganic and Bioinorganic Chemistry
(2011) · Wiley eBooks · doi:10.1002/9781119951438 · Cited by 1,585
Chemical biology of anticancer gold(iii) and gold(i) complexes
Zou, T., Lum, C. T., Lok, C.-N., Zhang, J.-J., & Che, C.-M. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00132c · Cited by 628
Aquaporins: important but elusive drug targets
Verkman, A. S., Anderson, M. O., & Papadopoulos, M. C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4226 · Cited by 586
Update on metal N-heterocyclic carbene complexes as potential anti-tumor metallodrugs
Liu, W., & Gust, R. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2016.09.004 · Cited by 351
Monti, D. M., Ferraro, G., Petruk, G., Maiore, L., Pane, F., Amoresano, A., Cinellu, M. A., & Merlino, A. (2017) · Dalton Transactions · doi:10.1039/c7dt02370g · Cited by 49
Metadata
- Authors
- Bertrand, B., & Casini, A.
- Venue
- Dalton Trans.
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2014
- Volume
- 43
- Issue
- 11
- Pages
- 4209-4219
- ISSN
- 1477-9226 (ISSN-L)
- 1477-9234
- OpenAlex
- W2166880800
- Cited by
- 441
- References
- 43
- FWCI
- 15.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.